Matthew Shawn Morris - Jun 22, 2022 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role
Chief Executive Officer, Director
Signature
/s/ Thomas Bartrum, as attorney-in-fact
Stock symbol
PRVA
Transactions as of
Jun 22, 2022
Transactions value $
-$4,022,518
Form type
4
Date filed
6/24/2022, 02:03 PM
Previous filing
Nov 26, 2021
Next filing
Jul 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock, $0.01 par value per share Options Exercise $140K +69.8K +57.37% $2.00 192K Jun 22, 2022 Direct
transaction PRVA Common Stock, $0.01 par value per share Sale -$1.87M -64.3K -33.57% $29.12 127K Jun 22, 2022 Direct F1, F2
transaction PRVA Common Stock, $0.01 par value per share Sale -$164K -5.52K -4.34% $29.65 122K Jun 22, 2022 Direct F1, F3
transaction PRVA Common Stock, $0.01 par value per share Options Exercise $155K +77.5K +63.69% $2.00 199K Jun 23, 2022 Direct
transaction PRVA Common Stock, $0.01 par value per share Sale -$794K -27.4K -13.77% $28.93 172K Jun 23, 2022 Direct F1, F4
transaction PRVA Common Stock, $0.01 par value per share Sale -$1.49M -50.1K -29.15% $29.68 122K Jun 23, 2022 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVA Stock Option (Right to Purchase) Options Exercise $0 -69.8K -1.26% $0.00 5.47M Jun 22, 2022 Common Stock 69.8K $2.00 Direct
transaction PRVA Stock Option (Right to Purchase) Options Exercise $0 -77.5K -1.42% $0.00 5.39M Jun 23, 2022 Common Stock 77.5K $2.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.54 to $29.53 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.54 to $29.88 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.32 to $29.31 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F5 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.32 to $29.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.